ASH-HSANZ Abstract Achievement Award

The following individuals received the ASH-HSANZ Abstract Achievement Award.

2023

James Kuzich, MBBS, FRACP, FRCPA
Peter MacCallum Cancer Centre, Australia
A Rare Cell State Underpins Diverse Mechanisms of Adaptive Resistance to CAR T-Cell Therapy in B-Cell Acute Lymphoblastic Leukemia

2022

Chanukya Colonne, BSc(Adv), MBBS, PhD
University of Sydney
A Putative Erythroid Synapse Linking Developing Erythroblasts and Macrophages in Erythroblastic Islands

2021

Katharine Lewis, BMBS, FRCPath, MRCPath
Sir Charles Gairdner Hospital Perth
High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients
Abstract #181

2020

Naranie Shanmuganathan, FRACP, FRCPA, MBBS
Royal Adelaide Hospital and SA Pathology
Mutated Cancer-Related Genes Detected at Diagnosis of CML and a Novel Class of Variant Associated with the Philadelphia Translocation Are Both Independent Predictors of Inferior Outcomes
Abstract #49

2019

Chong Chyn Chua, MBBS, FRACP, FRCPA
The Alfred Hospital and Monash University
Anti-Leukemic Activity of Single Agent Venetoclax in Newly Diagnosed Acute Myeloid Leukemia: A Sub-Set Analysis of the Caveat Study
Abstract #462

2018 Recipient

Naranie Shanmuganathan, MBBS
Royal Adelaide Hospital and SA Pathology
The e13a2 BCR-ABL1 Transcript Is Associated with Higher Rates of Molecular Recurrence after Treatment-Free Remission Attempts: Retrospective Analysis of the Adelaide Cohort
Abstract #1731

2017 Recipient

Joshua Tobin, MD
Princess Alexandra Hospital
The Tumor Microenvironment Is Independently Prognostic of Conventional and Clinicogenetic Risk Models in Follicular Lymphoma
Abstract #728